| 000 | 01916 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514224942.0 | ||
| 264 | 0 | _c20051227 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.CIR.0000165065.82609.3D _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlein, Liviu | |
| 245 | 0 | 0 |
_aLower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. _h[electronic resource] |
| 260 |
_bCirculation _cMay 2005 |
||
| 300 |
_a2454-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aCardiovascular Diseases |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xmortality |
| 650 | 0 | 4 | _aHospital Mortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMilrinone _xadministration & dosage |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSodium _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aO'Connor, Christopher M | |
| 700 | 1 | _aLeimberger, Jeffrey D | |
| 700 | 1 | _aGattis-Stough, Wendy | |
| 700 | 1 | _aPiña, Ileana L | |
| 700 | 1 | _aFelker, G Michael | |
| 700 | 1 | _aAdams, Kirkwood F | |
| 700 | 1 | _aCaliff, Robert M | |
| 700 | 1 | _aGheorghiade, Mihai | |
| 773 | 0 |
_tCirculation _gvol. 111 _gno. 19 _gp. 2454-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.CIR.0000165065.82609.3D _zAvailable from publisher's website |
| 999 |
_c15533494 _d15533494 |
||